The three-year agreement will provide SANUWAVE with an opportunity to monetize the extracorporeal shock wave therapy system approved by the U.S. Food and Drug Administration. The system is intended to treat multiple orthopedic conditions that have failed to respond to conservative treatment.
Premier Shockwave is a mobile OssaTron service provider and SANUWAVE Health is a shock wave technology company.
More Articles on Devices:
1st reverse shoulder surgery with DJO Surgical’s blended vitamin E polyethylene performed
Can generic orthopedic device start-ups disrupt medtech giants?
Smith & Nephew introduces lesser toe repair system
